Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.

Phase 4 Completed 76 enrolled HRA Pharma

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purposes of this study are to compare the effects on ovarian activity of quick starting a Combined Oral Contraceptive Pill (COCP) after ellaOne® or placebo intake.

Timeline

Start: 2012-03
Primary completion: 2012-08
Completion: 2012-08

Publications

Cameron ST, Berger C, Michie L, Klipping C, Gemzell-Danielsson K. The effects on ovarian activity of ulipristal acetate when 'quickstarting' a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study. Hum Reprod. 2015 Jul;30(7):1566-72. doi: 10.1093/humrep/dev115. Epub 2015 May 20.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ulipristal Acetate	Unknown	30 mg	Oral
Comparator	Levonorgestrel	Small molecule	150 ug	Oral
Comparator	ethinyl estradiol	Small molecule	30 ug	Oral

Indications

No indication recorded.